Impact of Tenofovir on Hepatitis Delta Virus Replication in the Swiss Human Immunodeficiency Virus Cohort Study.
Détails
ID Serval
serval:BIB_BA76B0AD3D71
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Impact of Tenofovir on Hepatitis Delta Virus Replication in the Swiss Human Immunodeficiency Virus Cohort Study.
Périodique
Clinical infectious diseases
Collaborateur⸱rice⸱s
Swiss HIV Cohort Study
ISSN
1537-6591 (Electronic)
ISSN-L
1058-4838
Statut éditorial
Publié
Date de publication
01/05/2017
Peer-reviewed
Oui
Volume
64
Numéro
9
Pages
1275-1278
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: ppublish
Publication Status: ppublish
Résumé
We analyzed changes in hepatitis B virus and hepatitis delta virus (HDV) viral loads (VL) during tenofovir-containing antiretroviral therapy among patients with a replicating HDV infection in the Swiss HIV Cohort Study. Only 28.6% experienced a ≥2.0 log reduction in HDV RNA, and 14.3% had undetectable HDV VL within 5 years.
Mots-clé
Adult, Anti-HIV Agents/therapeutic use, Cohort Studies, Female, HIV Infections/complications, HIV Infections/drug therapy, Hepatitis B virus/isolation & purification, Hepatitis B, Chronic/complications, Hepatitis B, Chronic/virology, Hepatitis D/virology, Hepatitis Delta Virus/drug effects, Hepatitis Delta Virus/isolation & purification, Hepatitis Delta Virus/physiology, Humans, Male, Middle Aged, Switzerland, Tenofovir/therapeutic use, Viral Load, Virus Replication/drug effects, coinfection, hepatitis delta virus, human immunodeficiency virus, replication, tenofovir
Pubmed
Web of science
Création de la notice
21/02/2017 17:58
Dernière modification de la notice
20/08/2019 15:28
Données d'usage
